- Home
- HIX vs AVTX Comparison
HIX vs AVTX Comparison
Compare HIX & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$14.27
Company Overview
Basic Information| Metric | HIX | AVTX |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 328.4M |
| IPO Year | 1998 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HIX | AVTX |
|---|---|---|
| Price | $3.98 | $14.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $40.57 |
| AVG Volume (30 Days) | 345.9K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $3.75 | $4.47 |
| 52 Week High | $4.39 | $24.27 |
Technical Indicators
Market Signals| Indicator | HIX | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 44.59 |
| Support Level | $3.89 | $13.01 |
| Resistance Level | $4.05 | $15.63 |
| Average True Range (ATR) | 0.04 | 0.93 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 68.75 | 44.60 |
Price Performance
Historical Comparison HIX
AVTX
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.